Annals of Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Annals of Oncology
Mar 17, 2024, 19:51 |
Insight
Tom Powles: New ESMO's guidlines for advanced bladder cancer Annals of Oncology - Enforumab Vedotin and pembrolizumab is the new standard of care
Tom Powles, Director of Barts Cancer Center, shared a post on X: "New ESMO's guidelines for…
Mar 15, 2024, 15:26 |
Insight
Enfortumab+pembrolizumab combination as the 1st line treatment of choice for advanced urothelial cancer - summary by Piotr J. Wysocki
Piotr J. Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital,…
Feb 28, 2024, 12:34 |
Blog
Erman Akkus: Early onset colorectal cancer, 2 recent studies
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Early onset colorectal cancer…
Feb 21, 2024, 18:13 |
Insight
Erman Akkus: Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Tremelimumab plus durvalumab (STRIDE)…
Feb 10, 2024, 15:34 |
Insight
Alessandro Russo: Our editorial on the potential role of ctDNA in resectable NSCLC undergoing neo-adj chemo
Alessandro Russo, Medical Oncologist at A.O. Papardo, Messina, recently shared the following insight on X/Twitter:…
Jan 4, 2024, 16:59 |
Insight
Vinay Prasad: When do the checkpoint inhibitors work
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Jan 3, 2024, 20:43 |
Opinion
Erman Akkus: Future biomarkers will be more than PD-L1 for ICI
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: “B-cell infiltration as a…
Dec 31, 2023, 06:06 |
Blog
David Gandara: “not so fast”
David Gandara, Director of Thoracic Oncology and Senior Advisor to the Director at University of…
Dec 15, 2023, 15:59 |
Insight
,
Opinion
Vivek Subbiah: Precision Medicine for FGFR in bladder cancer has now arrived
Vivek Subbiah shared on X/Twitter: “Just published Annals of Oncology. Pleased to share our editorial "Unlocking…
Nov 21, 2023, 13:57 |
Blog
Vivek Subbiah: Honored to co-author with brilliant "Guru" of bladder cancer Guru Sonpavde.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
1
2
3
4
All:
32
Posts:
21 - 30
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
Facebook
RSS Feed
Twitter
Linkedin
Youtube